209
Participants
Start Date
April 26, 2017
Primary Completion Date
June 29, 2018
Study Completion Date
June 29, 2018
ALX-101 Gel 1.5% and ALX-101 Gel Vehicle
Bilateral application of ALX-101 Gel 1.5% and ALX-101 Gel Vehicle
ALX-101 Gel 5% and ALX-101 Gel Vehicle
Bilateral application of ALX-101 Gel 5% and ALX-101 Gel Vehicle
Ralexar Investigational Site 20, New York
Ralexar Investigational Site 30, Stony Brook
Ralexar Investigational Site 13, Richmond
Ralexar Investigational Site 28, Charlotte
Ralexar Investigational Site 6, Spartanburg
Ralexar Investigational Site 29, Snellville
Ralexar Investigational Site 1, Miami
Ralexar Investigational Site 22, Tampa
Ralexar Investigational Site 14, Pinellas Park
Ralexar Investigational Site 21, Birmingham
Ralexar Investigational Site 35, Anniston
Ralexar Investigational Site 9, Nashville
Ralexar Investigational Site 32, Louisville
Ralexar Investigational Site 7, Louisville
Ralexar Investigational Site 12, Beachwood
Ralexar Investigational Site 5, Cincinnati
Ralexar Investigational Site 17, New Albany
Ralexar Investigational Site 11, Warren
Ralexar Investigational Site 15, Fridley
Ralexar Investigational Site 25, Saint Joseph
Ralexar Investigational Site 3, Oklahoma City
Ralexar Investigational Site 4, Plano
Ralexar Investigational Site 2, San Antonio
Ralexar Investigational Site 19, Austin
Ralexar Investigational Site 31, Austin
Ralexar Investigational Site 26, Albuquerque
Ralexar Investigational Site 23, Los Angeles
Ralexar Investigational Site 27, Santa Monica
Ralexar Investigational Site 24, Oceanside
Ralexar Investigational Site 34, San Diego
Ralexar Investigational Site 16, San Diego
Ralexar Investigational Site 33, San Diego
Ralexar Investigational Site 18, Laguna Hills
Ralexar Investigational Site 10, Spokane
Ralexar Investigational Site 8, Johnston
Ralexar Therapeutics, Inc.
INDUSTRY